Author(s)

Stuart S. Winter, Jerec Ricci, Li Luo, Debbie M. Lovato, Hadya M. Khawaja, Tasha Serna-Gallegos, Natalie DeBassige, Richard S. Larson

Department of Pathology, Biostatistics Core the UNM Clinical and Translation Science Center, Albuquerque, USA.
Department of Pathology, Pathology the UNM Clinical and Translation Science Center, Albuquerque, USA.
Departments of Pediatrics Division of Pediatric Hematology/Oncology, Albuquerque, USA;.
The Department of Family and Community Medicine, The University of New Mexico Health Sciences Center, Albuquerque, USA.

Purpose: In acute lymphoblastic leukemia (ALL), multidrug resistance is often mediated by AT- Pase Binding Cassette (ABC) proteins, which principally involve ABCC1 (multidrug resistance protein 1, MRP1) and ABCB1 (multidrug resistance 1, MDR1). However, direct comparisons between the differential effects of ABCC1 and ABCB1 have been difficult, since identical cell lines with differential expression of these transporters have not been developed. Experimental Design: In this study, we developed and compared the biological profiles of Jurkat cell lines that selectively over-expressed ABCC1 and ABCB1. Vincristine (VCR) plays an important role in the treatment of T-lineage ALL (T-ALL), and is often the first drug given to newly-diagnosed patients. Because of its importance in treatment, we provide descalating, sub-lethal doses of VCR to Jurkat cells, and extended our observations to expression profiling of newly diagnosed patients with T-ALL. Results: We found that VCR-resistant cells over-expressed ABCC1 nearly 30-fold. The calcein AM assay confirmed that VCR-resistant cells actively extruded VCR, and that ABCC1-mediated drug resistance conferred a different spectrum of multidrug resistance than other T-ALL induction agents. siRNA experiments that blocked ABCC1 export confirmed that VCR resistance could be reversed in vitro. Analyses of T-lymphoblasts obtained from 100 newly diagnosed T-ALL patients treated on Children’s Oncology Group Phase III studies 9404 and AALL0434 that induction failure could be could be partially explained by the over-expression of ABCC1 and ABCB1. Conclusions: Taken together, these results suggest that over-expression of ABC transporters plays a contributing role in mediating treatment failure in T-ALL, and underscore the need to employ alternate treatment approaches in patients for whom induction failed or for those with relapsed disease.

ATP Binding Cassette Proteins C1 and B1; Multi-Drug Resistance; T-Lineage Acute Lymphoblastic Leukemia

Winter, S. , Ricci, J. , Luo, L. , Lovato, D. , Khawaja, H. , Serna-Gallegos, T. , DeBassige, N. and Larson, R. (2013) ATP binding cassette C1 (ABCC1/MRP1)-mediated drug efflux contributes to disease progression in T-lineage acute lymphoblastic leukemia. Health, 5, 41-50. doi: 10.4236/health.2013.55A005.